Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease

Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease

BACKGROUND: Inflammatory bowel disease (IBD) is characterized by a chronic inflammation of the gut, partly driven by defects in the innate immune system. Considering the central role of inflammasome signaling in innate immunity, we studied inflammasome components in IBD mucosa. METHODS: Expression o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammatory Bowel Diseases 2015, Vol.21 (11), p.2673-2682
Hauptverfasser: Vanhove, Wiebe, Peeters, Paul, Staelens, Dominiek, Schraenen, Anica, Van der Goten, Jan, Cleynen, Isabelle, De Schepper, Seppe, Van Lommel, Leentje, Reynaert, Niki L, Schuit, Frans, Van Assche, Gert, Ferrante, Marc, De Hertogh, Gert, Wouters, Emiel F.M, Rutgeerts, Paul, Vermeire, Séverine, Nys, Kris, Arijs, Ingrid
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND: Inflammatory bowel disease (IBD) is characterized by a chronic inflammation of the gut, partly driven by defects in the innate immune system. Considering the central role of inflammasome signaling in innate immunity, we studied inflammasome components in IBD mucosa. METHODS: Expression of genes encoding inflammasome sensor subunits was investigated in colonic mucosal biopsies from 2 cohorts of patients with IBD and controls. RESULTS: A significant upregulation (>2-fold change in expression, false discovery rate
ISSN:1078-0998